Methods of inhibiting cancer metastasis using polypeptides targeting chemokine receptors April 28, 2003
NIH licensing opportunity: methods of inhibiting amino acid formation and tumor angiogenesis April 25, 2003
Tyrosine kinase inhibitors and their use in cancer, angiogenesis, etc., claimed by Allergan April 25, 2003
Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer April 24, 2003